The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Biochemical recurrence after salvage prostate bed radiotherapy captured on PSMA-PET: Patient characteristics and distribution of recurrent disease.
 
Miles Hsu
Employment - Abbvie (I)
Stock and Other Ownership Interests - Abbvie; Abbvie (I)
 
Xinhe Shan
No Relationships to Disclose
 
Neha Vapiwala
No Relationships to Disclose
 
Rebecca Zhang
No Relationships to Disclose
 
Austin Pantel
Consulting or Advisory Role - Blue Earth Diagnostics; GE Healthcare; Progenics
Research Funding - Progenics (Inst)
Travel, Accommodations, Expenses - Blue Earth Diagnostics; GE Healthcare
 
Eva Berlin
No Relationships to Disclose
 
Vivek Narayan
Honoraria - Pfizer
Consulting or Advisory Role - Amgen; AstraZeneca; Exelixis; Janssen Oncology; Merck; Myovant Sciences; Pfizer/EMD Serono; Regeneron
Research Funding - Bristol-Myers Squibb (Inst); Janssen (Inst); Merck (Inst); Pfizer (Inst); Tmunity Therapeutics, Inc. (Inst)
Travel, Accommodations, Expenses - Exelixis
 
Samuel U Takvorian
Stock and Other Ownership Interests - Bluebird Bio (I); Gilead Sciences (I); Johnson & Johnson (I); Merck (I); Novartis (I); Pfizer (I); Pfizer (I); Portola Pharmaceuticals (I)
Consulting or Advisory Role - AstraZeneca/Merck; Boehringer Ingelheim (I); Genentech; Health Advances; Novartis (I); Novocure (I)
Research Funding - AstraZeneca (I); Lilly (I); Pfizer; Trizell (I)
 
David J. Vaughn
No Relationships to Disclose
 
Naomi B. Haas
Consulting or Advisory Role - AVEO; Calithera Biosciences; Eisai; Exelixis; Merck Sharp & Dohme; Pfizer; Roche/Genentech
Expert Testimony - Lilly (I)